INCENDIA PHARMA

Serial Number 79329010
Registration 7088835
700

Registration Progress

Application Filed
Oct 25, 2021
Under Examination
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered
Jun 27, 2023

Trademark Image

INCENDIA PHARMA

Basic Information

Serial Number
79329010
Registration Number
7088835
Filing Date
October 25, 2021
Registration Date
June 27, 2023
Published for Opposition
April 11, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 27, 2023
Registration
Registered
Classes
005 042

Rights Holder

Incendia Pharma AB

64
Address
Södergatan 26
SE-211 34 Malmö
SE

Ownership History

Incendia Pharma AB

Original Applicant
64
SE

Incendia Pharma AB

Owner at Publication
64
SE

Incendia Pharma AB

Original Registrant
64
SE

Legal Representation

Attorney
Scott Rogers

USPTO Deadlines

Next Deadline
1275 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20230627)
Due Date
June 27, 2029
Grace Period Ends
December 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Oct 16, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 27, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 27, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 27, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 27, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 27, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 11, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
May 24, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 24, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Apr 13, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 22, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 22, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 18, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 29, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 29, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 9, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 8, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 4, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 23, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemical preparations for medical, pharmaceutical or veterinary use, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceutical preparations, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceuticals, namely, gut microbiome stabilizators and quorum sensing inhibitors
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Pharmaceutical research and development
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"